iShares China Large-Cap ETF vs Kimberly Clark Corp — how do they compare? iShares China Large-Cap ETF trades at $34.18 (market cap $3.86B), while Kimberly Clark Corp trades at $98.09 (market cap $32.51B). The key difference: Kimberly Clark Corp is far larger — about 8.4× iShares China Large-Cap ETF's market cap, and Kimberly Clark Corp pays a 5.24% dividend while iShares China Large-Cap ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold iShares China Large-Cap ETF for 149 Days and Kimberly Clark Corp for 93 Days on average.
| FXI | KMB | |
|---|---|---|
Market Cap | $3.86B | $32.51B |
Volume | 16,323,837 | 6,139,913 |
52-Week High | $41.08 | $121.44 |
52-Week Low | $31.59 | $93.05 |
Typical Hold Time | 149 Days | 93 Days |
Sector | — | Consumer Staples |
Enterprise Value | — | $38.07B |
Dividend Yield | — | 5.24% |
Signals from Pluang's Aura AI — not financial advice
FXI (iShares China Large-Cap ETF) trades at $34.30, up 2.63% on the day, but technical indicators signal a bearish trend with 17 sell signals versus 1 buy. The ETF faces headwinds from China's economic challenges and geopolitical tensions, though some analysts highlight its attractive valuation at half the S&P 500's P/E ratio. Recent news focuses on U.S.-China relations and export dynamics.
The outlook remains cautious due to China's industrial overcapacity and weak domestic consumption. While valuation appears compelling, political risks and technical weakness suggest limited near-term upside. Investors should weigh the discount against ongoing macroeconomic pressures in China.
Kimberly-Clark (KMB) trades at $96.48, down 0.3% on the day, showing bearish technical signals with the current price near support at $96. The company maintains strong profitability with 11.79% net margins and has beaten earnings estimates in 2 of the last 3 quarters, though Q2 2026 missed expectations. Recent executive transitions and the pending Kenvue acquisition create both strategic opportunities and integration risks.
KMB offers a compelling 5.3% dividend yield with 54 consecutive years of increases, but cash flow concerns and acquisition-related debt pose sustainability questions. Analyst consensus remains cautiously optimistic with a $117.25 price target suggesting 21% upside, though the stock faces near-term headwinds from technical weakness and merger execution risks.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
The fund generally will invest at least 80% of its assets in the component securities of its underlying index and in investments that have economic characteristics that are substantially identical to the component securities of its underlying index. The index designed to measure the performance of the largest companies in the Chinese equity market that trade on the Stock Exchange of Hong Kong and are available to international investors. The fund is non-diversified.
Read more on FXI →With around half of sales from personal care and another third from tissue products, Kimberly-Clark sits as a leading manufacturer of tissue and hygiene realm. Its brand mix includes Huggies, Pull-Ups, Kotex, Depend, Kleenex, and Cottonelle. The firm also operates K-C Professional, which partners with businesses to provide safety and sanitary products for the workplace. Kimberly-Clark generates just over of half its sales in North America and more than 10% in Europe, with the rest primarily concentrated in Asia and Latin America.
Read more on KMB →